Ownership history in FOX RUN MANAGEMENT, L.L.C. · 9 quarters on record
This page tracks every 13F SEC filing in which FOX RUN MANAGEMENT, L.L.C. reported a position in ADAPTIVE BIOTECHNOLOGIES COR (ADPT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 39,983 | +19,788 | +98.0% | 0.09% | $598K | $14.96 |
| 2025 Q2 | REDUCED | 20,195 | -1,370 | -6.4% | 0.04% | $235K | $11.65 |
| 2025 Q1 | ADDED | 21,565 | +1,631 | +8.2% | 0.02% | $160K | $7.43 |
| 2024 Q4 | REDUCED | 19,934 | -1,790 | -8.2% | 0.02% | $120K | $5.99 |
| 2023 Q2 | ADDED | 21,724 | +1,375 | +6.8% | 0.04% | $146K | $6.71 |
| 2023 Q1 | ADDED | 20,349 | +1,124 | +5.8% | 0.06% | $180K | $8.83 |
| 2022 Q4 | ADDED | 19,225 | +4,734 | +32.7% | 0.06% | $147K | $7.64 |
| 2022 Q1 | ADDED | 14,491 | +5,579 | +62.6% | 0.11% | $201K | $13.88 |
| 2021 Q3 | INITIATED | 8,912 | — | — | 0.19% | $303K | $33.99 |
As of 2025 Q4 — sorted by position size